Form 4: Treace Medical Concepts Director Betsy Hanna Reports Stock Transactions

Director Betsy Hanna reported the acquisition of 23,917 shares of Treace Medical Concepts, Inc. through restricted stock units and the disposal of the same amount.

Summary

• Betsy Hanna, a director of Treace Medical Concepts, Inc. (TMCI), filed a Form 4 detailing changes in beneficial ownership.
• On May 20, 2025, Hanna acquired 23,917 shares of common stock through restricted stock units (RSUs) at a price of $0.
• These RSUs will vest on the earlier of May 20, 2026, or the date of the 2026 annual meeting of stockholders, contingent upon Hanna's continued service to the Issuer.
• Hanna also disposed of 23,917 shares.
• Following these transactions, Hanna beneficially owns 45,243 shares, which includes 23,917 restricted stock units.
• Hanna has voluntarily deferred receipt of shares issuable upon settlement of the RSUs until a change in control or separation of service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard filing related to stock transactions by a director. The acquisition of RSUs can be seen as a slightly positive sign, indicating confidence in the company's future.

Positives

• The acquisition of RSUs indicates confidence in the company's future performance, as the vesting is tied to continued service and the company's annual meeting.

Future Outlook

The vesting of the RSUs is contingent upon Hanna's continued service and the company's performance until the vesting date, indicating a long-term commitment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Director, Treace Medical Concepts, TMCI, Hanna, Stock Transaction